Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Pharmala Biotech Hldg Inc (MDXXF)

Pharmala Biotech Hldg Inc (MDXXF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield (Fwd) N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector N/A
  • INDUSTRY GROUPING N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0687 +8.15%
on 02/02/26
0.0816 -8.95%
on 01/28/26
+0.0004 (+0.54%)
since 01/22/26
3-Month
0.0614 +21.01%
on 12/08/25
0.0900 -17.44%
on 12/16/25
-0.0081 (-9.83%)
since 11/26/25
52-Week
0.0614 +21.01%
on 12/08/25
0.1550 -52.06%
on 03/24/25
-0.0607 (-44.96%)
since 02/26/25

Most Recent Stories

More News
PharmAla Signs Drug Donation Agreement for MDMA-Assisted Therapy Clinical Trial in Fibromyalgia

TORONTO, Feb. 26, 2026 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (CSE: MDMA)(OTCQB: MDXXF) , a biotechnology company focused on the research, development, and manufacturing of LaNeo™ MDMA...

MDXXF : 0.0743 (-7.01%)
MDMA.CN : 0.0950 (unch)
PharmAla To Supply Amsterdam UMC with LaNeo™ MDMA, Including Development of New Single-Capsule Stability Data

TORONTO, Feb. 23, 2026 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (CSE: MDMA)(OTCQB: MDXXF) , a biotechnology company focused on the research, development, and manufacturing of LaNeo™ MDMA...

MDXXF : 0.0743 (-7.01%)
MDMA.CN : 0.0950 (unch)
PharmAla Announces Changes to Board of Directors

TORONTO, Feb. 10, 2026 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“ PharmAla ” or the “ Company ”) (CSE: MDMA) (OTCQB:MDXXF), a biotechnology company focused on the research, development,...

MDXXF : 0.0743 (-7.01%)
MDMA.CN : 0.0950 (unch)
PharmAla To Supply Østfold Hospital Trust with LaNeo™ MDMA for Clinical Research

TORONTO, Jan. 08, 2026 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“ PharmAla ” or the “ Company ”) (CSE: MDMA) (OTCQB:MDXXF), a biotechnology company focused on the research, development,...

MDXXF : 0.0743 (-7.01%)
MDMA.CN : 0.0950 (unch)
PharmAla Issues Audited Year End 2025 and Unaudited Q1 Fiscal 2026 Financial Statements

TORONTO, Dec. 24, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“ PharmAla ” or the “ Company ”) (CSE: MDMA) (OTC: MDXXF), a biotechnology company focused on the research, development,...

MDXXF : 0.0743 (-7.01%)
MDMA.CN : 0.0950 (unch)
PharmAla Biotech Australia Contracts with UK-based CDMO for Manufacture of ALA-002 Drug Substance

TORONTO, Dec. 15, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“ PharmAla ” or the “ Company ”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development,...

MDXXF : 0.0743 (-7.01%)
MDMA.CN : 0.0950 (unch)
PharmAla Biotech Completes Release Testing on Australian-Made LaNeo Capsules

TORONTO, Dec. 10, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“ PharmAla ” or the “ Company ”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development,...

MDXXF : 0.0743 (-7.01%)
MDMA.CN : 0.0950 (unch)
PharmAla Files Final Base Shelf Prospectus and Signs Term Sheet with Radium Capital

TORONTO, Nov. 03, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“ PharmAla ” or the “ Company ”) (CSE: MDMA) (OTCQB:MDXXF), a biotechnology company focused on the research, development,...

MDXXF : 0.0743 (-7.01%)
MDMA.CN : 0.0950 (unch)
PharmAla Launches Nexus Portal for MDMA Prescribers and Therapists

TORONTO, Oct. 08, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“ PharmAla ” or the “ Company ”) (CSE: MDMA) (OTCQB:MDXXF), a biotechnology company focused on the research, development,...

MDXXF : 0.0743 (-7.01%)
MDMA.CN : 0.0950 (unch)
PharmAla Completes Shipment of LaNeo™ MDMA to Johns Hopkins

TORONTO, Oct. 02, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“ PharmAla ” or the “ Company ”) (CSE: MDMA) (OTCQB:MDXXF), a biotechnology company focused on the research, development,...

MDXXF : 0.0743 (-7.01%)
MDMA.CN : 0.0950 (unch)

Key Turning Points

3rd Resistance Point 0.0743
2nd Resistance Point 0.0743
1st Resistance Point 0.0743
Last Price 0.0743
1st Support Level 0.0743
2nd Support Level 0.0743
3rd Support Level 0.0743

See More

52-Week High 0.1550
Fibonacci 61.8% 0.1192
Fibonacci 50% 0.1082
Fibonacci 38.2% 0.0972
Last Price 0.0743
52-Week Low 0.0614

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar